IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 175 filers reported holding IMMUNOMEDICS INC in Q1 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $145,000 | +49.5% | 1,700 | -38.2% | 0.01% | +42.9% |
Q2 2020 | $97,000 | +162.2% | 2,750 | 0.0% | 0.01% | +133.3% |
Q1 2020 | $37,000 | -36.2% | 2,750 | 0.0% | 0.00% | -25.0% |
Q4 2019 | $58,000 | +61.1% | 2,750 | 0.0% | 0.00% | +33.3% |
Q3 2019 | $36,000 | -5.3% | 2,750 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $38,000 | -28.3% | 2,750 | 0.0% | 0.00% | -25.0% |
Q1 2019 | $53,000 | +35.9% | 2,750 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $39,000 | -31.6% | 2,750 | 0.0% | 0.00% | -20.0% |
Q3 2018 | $57,000 | -12.3% | 2,750 | 0.0% | 0.01% | -16.7% |
Q2 2018 | $65,000 | +6.6% | 2,750 | -33.7% | 0.01% | +20.0% |
Q1 2018 | $61,000 | -9.0% | 4,150 | 0.0% | 0.01% | -16.7% |
Q4 2017 | $67,000 | +15.5% | 4,150 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $58,000 | +3.6% | 4,150 | -34.1% | 0.01% | +20.0% |
Q2 2017 | $56,000 | +36.6% | 6,300 | 0.0% | 0.01% | +25.0% |
Q1 2017 | $41,000 | +115.8% | 6,300 | +18.9% | 0.00% | +100.0% |
Q4 2016 | $19,000 | +11.8% | 5,300 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $17,000 | +41.7% | 5,300 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $12,000 | -7.7% | 5,300 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $13,000 | 0.0% | 5,300 | +23.3% | 0.00% | -50.0% |
Q4 2015 | $13,000 | +85.7% | 4,300 | 0.0% | 0.00% | +100.0% |
Q3 2015 | $7,000 | -58.8% | 4,300 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $17,000 | +6.2% | 4,300 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $16,000 | -23.8% | 4,300 | 0.0% | 0.00% | -33.3% |
Q4 2014 | $21,000 | +31.2% | 4,300 | 0.0% | 0.00% | +50.0% |
Q3 2014 | $16,000 | 0.0% | 4,300 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $16,000 | -11.1% | 4,300 | 0.0% | 0.00% | -33.3% |
Q1 2014 | $18,000 | -10.0% | 4,300 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $20,000 | -25.9% | 4,300 | 0.0% | 0.00% | -25.0% |
Q3 2013 | $27,000 | +17.4% | 4,300 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $23,000 | – | 4,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 17,714,461 | $368,992,000 | 16.94% |
ACUTA CAPITAL PARTNERS, LLC | 2,055,500 | $42,816,000 | 15.27% |
Foresite Capital Management III, LLC | 2,691,729 | $56,069,000 | 12.37% |
Foresite Capital Management IV, LLC | 1,231,543 | $25,653,000 | 8.41% |
NEXTHERA CAPITAL LP | 1,398,577 | $29,132,000 | 5.58% |
Palo Alto Investors LP | 5,013,764 | $104,437,000 | 4.22% |
Ghost Tree Capital, LLC | 883,823 | $18,410,000 | 3.91% |
First Light Asset Management, LLC | 1,151,622 | $23,988,000 | 3.87% |
DLD Asset Management, LP | 3,403,000 | $70,918,000 | 3.51% |
RA Capital Management | 3,119,778 | $64,985,000 | 3.47% |